Hyaluronidase Power Injection Market

Hyaluronidase is a protein that helps the body to absorb fluids that have been injected into the body. It is also used to treat dehydration. Hyaluronidase power injections are injected into muscles or tissues and it facilitates reabsorption of fluids or blood from the tissue. It breaks down the hyaluronic acid which acts as an adhesive between cells and thereby enabling quicker absorption of fluids that have been injected into the body.
Hyaluronidase Power Injection Market contains market size and forecasts of Hyaluronidase Power Injection in global, including the following market information:
Global Hyaluronidase Power Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hyaluronidase Power Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hyaluronidase Power Injection companies in 2021 (%)
The global Hyaluronidase Power Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Synthetic Animal-Derived Hyaluronidase Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hyaluronidase Power Injection include PrimaPharm, Sun Pharmaceuticals Industries, Bausch Health, Halozyme Therapeutics, CooperSurgical Fertility, Amphastar Pharmaceuticals, Shreya Life Science, Stemcell Technologies and Anika Therapeutics. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hyaluronidase Power Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyaluronidase Power Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hyaluronidase Power Injection Market Segment Percentages, by Type, 2021 (%)
Synthetic Animal-Derived Hyaluronidase
Bio-Engineered Hyaluronidase
Global Hyaluronidase Power Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hyaluronidase Power Injection Market Segment Percentages, by Application, 2021 (%)
Chemotherapy
Dermatology
Ophthalmology
Plastic Surgery
Others
Global Hyaluronidase Power Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hyaluronidase Power Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyaluronidase Power Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hyaluronidase Power Injection revenues share in global market, 2021 (%)
Key companies Hyaluronidase Power Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hyaluronidase Power Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
PrimaPharm
Sun Pharmaceuticals Industries
Bausch Health
Halozyme Therapeutics
CooperSurgical Fertility
Amphastar Pharmaceuticals
Shreya Life Science
Stemcell Technologies
Anika Therapeutics